Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluating the efficacy of post-operative chemotherapy after curative resection of stage IV gastric cancer with synchronous oligo metastasis: a multicenter retrospective study.
Yamaguchi T, Takashima A, Nagashima K, Kumagai K, Yamada T, Terashima M, Yabusaki H, Nishikawa K, Tanabe K, Yunome G, Kawachi Y, Yamada T, Fukagawa T, Kinoshita T, Watanabe M, Ishiyama K, Inoue K, Boku N. Yamaguchi T, et al. Among authors: kawachi y. Gastric Cancer. 2023 Mar;26(2):307-316. doi: 10.1007/s10120-023-01363-8. Epub 2023 Jan 25. Gastric Cancer. 2023. PMID: 36695982
A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A).
Fukagawa T, Katai H, Mizusawa J, Nakamura K, Sano T, Terashima M, Ito S, Yoshikawa T, Fukushima N, Kawachi Y, Kinoshita T, Kimura Y, Yabusaki H, Nishida Y, Iwasaki Y, Lee SW, Yasuda T, Sasako M; Stomach Cancer Study Group of the Japan Clinical Oncology Group. Fukagawa T, et al. Among authors: kawachi y. Gastric Cancer. 2018 Jan;21(1):68-73. doi: 10.1007/s10120-017-0701-1. Epub 2017 Feb 13. Gastric Cancer. 2018. PMID: 28194522
Four courses versus eight courses of adjuvant S-1 for patients with stage II gastric cancer (JCOG1104 [OPAS-1]): an open-label, phase 3, non-inferiority, randomised trial.
Yoshikawa T, Terashima M, Mizusawa J, Nunobe S, Nishida Y, Yamada T, Kaji M, Fukushima N, Hato S, Choda Y, Yabusaki H, Yoshida K, Ito S, Takeno A, Yasuda T, Kawachi Y, Katayama H, Fukuda H, Boku N, Sano T, Sasako M. Yoshikawa T, et al. Among authors: kawachi y. Lancet Gastroenterol Hepatol. 2019 Mar;4(3):208-216. doi: 10.1016/S2468-1253(18)30383-2. Epub 2019 Jan 22. Lancet Gastroenterol Hepatol. 2019. PMID: 30679107 Clinical Trial.
Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
Yamaguchi T, Takashima A, Nagashima K, Makuuchi R, Aizawa M, Ohashi M, Tashiro K, Yamada T, Kinoshita T, Hata H, Kawachi Y, Kawabata R, Tsuji T, Hihara J, Sakamoto T, Fukagawa T, Katai H, Higuchi K, Boku N. Yamaguchi T, et al. Among authors: kawachi y. Ann Surg Oncol. 2020 Jan;27(1):284-292. doi: 10.1245/s10434-019-07697-x. Epub 2019 Sep 18. Ann Surg Oncol. 2020. PMID: 31535301
Impact of COVID-19 on gastric cancer treatment in Japanese high-volume centers: a JCOG stomach cancer study group survey.
Tokunaga M, Yoshikawa T, Boku N, Nishida Y, Tanahashi T, Yamada T, Haruta S, Etoh T, Hirahara N, Kawachi Y, Tsuji K, Kinoshita T, Kanazawa T, Tokumoto N, Fujita J, Terashima M. Tokunaga M, et al. Among authors: kawachi y. Surg Today. 2022 Feb;52(2):231-238. doi: 10.1007/s00595-021-02329-y. Epub 2021 Jul 20. Surg Today. 2022. PMID: 34286401 Free PMC article.
Prediction of the peritoneal recurrence via the macroscopic diagnosis of the serosal invasion in patients with gastric cancer: Supplementary analysis of JCOG0110.
Terashima M, Sano T, Mizusawa J, Umemura K, Tokunaga M, Omori T, Cho H, Hasegawa Y, Akiyama Y, Tsujimoto H, Kawashima Y, Kawachi Y, Lee SW, Kano K, Hasegawa H, Boku N, Yoshikawa T, Sasako M. Terashima M, et al. Among authors: kawachi y. Eur J Surg Oncol. 2022 Aug;48(8):1753-1759. doi: 10.1016/j.ejso.2022.01.015. Epub 2022 Jan 19. Eur J Surg Oncol. 2022. PMID: 35082047
Conversion surgery for stage IV gastric cancer: a multicenter retrospective study.
Kano Y, Ichikawa H, Hanyu T, Muneoka Y, Ishikawa T, Aizawa M, Matsuki A, Yabusaki H, Bamba T, Nakagawa S, Kobayashi K, Kuwabara S, Makino S, Kawachi Y, Naito T, Tani T, Hirukawa H, Tada T, Shimada Y, Sakata J, Wakai T. Kano Y, et al. Among authors: kawachi y. BMC Surg. 2022 Dec 14;22(1):428. doi: 10.1186/s12893-022-01874-8. BMC Surg. 2022. PMID: 36517780 Free PMC article.
5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer.
Yoshikawa T, Terashima M, Mizusawa J, Nunobe S, Nishida Y, Yamada T, Kaji M, Nomura T, Hato S, Choda Y, Yabusaki H, Yoshida K, Misawa K, Masuzawa T, Tsuda M, Kawachi Y, Katayama H, Fukuda H, Kurokawa Y, Boku N, Sano T, Sasako M. Yoshikawa T, et al. Among authors: kawachi y. Gastric Cancer. 2024 Jan;27(1):155-163. doi: 10.1007/s10120-023-01447-5. Epub 2023 Nov 21. Gastric Cancer. 2024. PMID: 37989806 Clinical Trial.
Macroscopic type is implicated in the prognostic impact of initial chemotherapy on peritoneal lavage cytology-positive gastric cancer with no other noncurative factors.
Kano Y, Ichikawa H, Aizawa M, Muneoka Y, Usui K, Hanyu T, Ishikawa T, Yabusaki H, Kobayashi K, Kuwabara S, Makino S, Kawachi Y, Miura K, Tajima Y, Shimada Y, Sakata J, Wakai T. Kano Y, et al. Among authors: kawachi y. Int J Clin Oncol. 2024 Mar 21. doi: 10.1007/s10147-024-02496-1. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38512543
400 results